InvestorsHub Logo
Followers 19
Posts 2069
Boards Moderated 0
Alias Born 12/04/2012

Re: None

Tuesday, 06/14/2016 11:34:44 AM

Tuesday, June 14, 2016 11:34:44 AM

Post# of 1675
Oramed's Flagship product

Oramed’s flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics around the world – allowing, amongst other things, type 2 patients to begin insulin therapy earlier without fear of needles. Oramed’s oral insulin is currently in advanced clinical trials under the US FDA for both type 1 and type 2 diabetes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ORMP News